Journal article
Effect of apolipoprotein E genotype on apolipoprotein B-100 metabolism in normolipidemic and hyperlipidemic subjects
EMM Ooi, ED Janus, SJ Grant, LMT Sinclair, PHR Barrett
Journal of Lipid Research | ELSEVIER | Published : 2010
DOI: 10.1194/jlr.M004705
Abstract
The effect of apolipoprotein (apo) E genotype on apoB-100 metabolism was examined in three normolipidemic apoE2/E2, five type III hyperlipidemic apoE2/E2, and five hyperlipidemic apoE3/E2 subjects using simultaneous administration of 131I-VLDL and 125I-LDL, and multi-compartmental modeling. Compared with normolipidemic apoE2/E2 subjects, type III hyperlipidemic E2/E2 subjects had increased plasma and VLDL cholesterol, plasma and VLDL triglycerides, and VLDL and intermediate density lipoprotein (IDL) apoB concentrations ( P < 0.05). These abnormalities were chiefly a consequence of decreased VLDL and IDL apoB fractional catabolic rate (FCR). Compared with hyperlipidemic E3/E2 subjects, type I..
View full abstractGrants
Funding Acknowledgements
This study was funded in part by a research grant from the National Heart Foundation of New Zealand. E.M.M.O. is supported by an A & A Saw Medical Research Fellowship and a National Health and Medical Research Council (NHMRC) Postdoctoral Research Fellowship. P.H.R.B. is an NHMRC Senior Research Fellow.